![]() Seagen Seagen (formerly known as Seattle Genetics) is a biotechnology company that develops and commercializes targeted therapies to treat cancer. | ![]() EpiPharm EpiPharm is a biopharmaceutical company developing non-invasive products for the treatment of benign skin tumours and hyperpigmentation disorders. | ||||
Founding Date | Founding Date 2017 | Founding Date 1998 | Founding Date 2014 | Founding Date N/A | Founding Date 2007 |
Type | Type Private | Type Subsidiary | Type Private | Type Private | Type Private |
Tags | |||||
Locations | Locations Watertown, US HQ Guangzhou, CN Hangzhou, CN | Locations Bothell, US HQ Mississauga, CA Hørsholm, DK Rueil Malmaison, FR München, DE Milano, IT Schiphol, NL see more | Locations Redmond, US HQ | Locations New York, US HQ | Locations Binningen, CH HQ |
Employees | Employees 5 | Employees 3,25622% increase | Employees 841% increase | Employees 2 | Employees 4 |
Funding | |||||
Latest funding round | Latest funding round $ 7m (over 7 years ago) | Latest funding round N/A | Latest funding round $ 50m (almost 9 years ago) | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised $ 7m | Total funding raised $ 164m | Total funding raised $ 76m | Total funding raised N/A | Total funding raised N/A |

Seagen (formerly known as Seattle Genetics) is a biotechnology company that develops and commercializes targeted therapies to treat cancer.
View company
Systimmune is a biopharmaceutical company focused on the treatment of cancer.
View companyAurora Biopharma is a company developing cancer immunotherapy.
View company
EpiPharm is a biopharmaceutical company developing non-invasive products for the treatment of benign skin tumours and hyperpigmentation disorders.
View company